Zhitong Finance App News, Nanjing Pharmaceutical (600713.SH) issued an announcement. The Shanghai Stock Exchange Listing Review Committee held its 24th review meeting in 2024 on October 16, 2024 to review the company's application to issue convertible corporate bonds to unspecified targets. According to the review results of the meeting, the company's application to issue convertible corporate bonds to unspecified targets met the issuance conditions, listing conditions and information disclosure requirements.

Zhitongcaijing · 10/16 07:57
Zhitong Finance App News, Nanjing Pharmaceutical (600713.SH) issued an announcement. The Shanghai Stock Exchange Listing Review Committee held its 24th review meeting in 2024 on October 16, 2024 to review the company's application to issue convertible corporate bonds to unspecified targets. According to the review results of the meeting, the company's application to issue convertible corporate bonds to unspecified targets met the issuance conditions, listing conditions and information disclosure requirements.